Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wands

Showing results (541-550 of 590) with videos related to

Pageof 59
Sort By:
Plos One|March 9, 2016
Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and ProgressionChiung-Kuei Huang, Yoshifumi Iwagami, Arihiro Aihara, et al.
Journal of Alzheimer'S Disease : JAD|September 6, 2002
Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's DiseaseDannie Etiene, Joanny Kraft, Neema Ganju, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2008
Evidence that CD8+ dendritic cells enable the development of gammadelta T cells that modulate airway hyperresponsivenessLaura Cook, Nobuaki Miyahara, Niyun Jin, et al.
Investigative Ophthalmology & Visual Science|January 20, 2009
Protective role of gammadelta T cells in spontaneous ocular inflammationRebecca L O'Brien, Molly A Taylor, Jacqueline Hartley, et al.
Journal of Hepatology|November 9, 2010
Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinomaSarah Beseme Nambotin, Lydie Lefrancois, Xavier Sainsily, et al.
Oncotarget|December 9, 2014
Aspartate β-Hydroxylase expression promotes a malignant pancreatic cellular phenotypeXiaoqun Dong, Qiushi Lin, Arihiro Aihara, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2018
Structural basis of O-GlcNAc recognition by mammalian 14-3-3 proteinsClifford A Toleman, Maria A Schumacher, Seok-Ho Yu, et al.
Cancer Letters|February 16, 2019
Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinomaKatsuya Nagaoka, Xuewei Bai, Kosuke Ogawa, et al.
Journal of Alzheimer'S Disease : JAD|March 8, 2005
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?Eric Steen, Benjamin M Terry, Enrique J Rivera, et al.
Oncotarget|November 26, 2019
Correction: Aspartate β-hydroxylase expression promotes a malignant pancreatic cellular phenotypeXiaoqun Dong, Qiushi Lin, Arihiro Aihara, et al.
Pageof 59

Showing results (541-550 of 590) with videos related to

Sort By:
Pageof 59
Plos One|March 9, 2016
Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and ProgressionChiung-Kuei Huang, Yoshifumi Iwagami, Arihiro Aihara, et al.
Journal of Alzheimer'S Disease : JAD|September 6, 2002
Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's DiseaseDannie Etiene, Joanny Kraft, Neema Ganju, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2008
Evidence that CD8+ dendritic cells enable the development of gammadelta T cells that modulate airway hyperresponsivenessLaura Cook, Nobuaki Miyahara, Niyun Jin, et al.
Investigative Ophthalmology & Visual Science|January 20, 2009
Protective role of gammadelta T cells in spontaneous ocular inflammationRebecca L O'Brien, Molly A Taylor, Jacqueline Hartley, et al.
Journal of Hepatology|November 9, 2010
Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinomaSarah Beseme Nambotin, Lydie Lefrancois, Xavier Sainsily, et al.
Oncotarget|December 9, 2014
Aspartate β-Hydroxylase expression promotes a malignant pancreatic cellular phenotypeXiaoqun Dong, Qiushi Lin, Arihiro Aihara, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2018
Structural basis of O-GlcNAc recognition by mammalian 14-3-3 proteinsClifford A Toleman, Maria A Schumacher, Seok-Ho Yu, et al.
Cancer Letters|February 16, 2019
Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinomaKatsuya Nagaoka, Xuewei Bai, Kosuke Ogawa, et al.
Journal of Alzheimer'S Disease : JAD|March 8, 2005
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?Eric Steen, Benjamin M Terry, Enrique J Rivera, et al.
Oncotarget|November 26, 2019
Correction: Aspartate β-hydroxylase expression promotes a malignant pancreatic cellular phenotypeXiaoqun Dong, Qiushi Lin, Arihiro Aihara, et al.
Pageof 59